To catalogue
DEP® cabazitaxel
DEP® cabazitaxel is Starpharma’s detergent-free version of cancer drug, Jevtana®, which is marketed by Sanofi Aventis to treat advanced prostate cancer, and is also under clinical development for a range of other cancer types, including testicular, ovarian, breast, bladder, and head and neck.
Product families
Applications
Healthcare & Pharma — Medical
- Other Medical Applications
Product Families
Pharmaceuticals & Nutraceuticals — Pharmaceutical Actives & Precursors
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Brand
- DEP
- Markets
- Healthcare & Pharma
- Technology
- Pharmaceuticals & Nutraceuticals
